Role of endothelin in endotoxin-induced sustained pulmonary hypertension in sheep

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 1, 1998, Pages 81-88

  Snapper, James R ^a,b   Thabes, John S ^a   Lefferts, Peter L ^a   Weixuan, L U ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN DERIVATIVE; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTOXIN; PROSTAGLANDIN DERIVATIVE; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENDOTOXEMIA; FEMALE; LUNG ARTERY PRESSURE; LUNG LYMPH FLOW; LUNG MECHANICS; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0031893437     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.1.95-05117     Document Type: Article

References (39)

1. Clowes, G. H., Jr., G. H. Farrington, W. Zuschneid, G. R. Cossette, and C. Saravis. 1970. Circulating factors in the etiology of pulmonary insufficiency and right heart failure accompanying severe sepsis (peritonitis). Ann. Surg. 171:663-678.
2. Sibbald, W. J., N. A. Paterson, R. L. Holliday, R. A. Anderson, T. R. Lobb, and J. H. Duff. 1978. Pulmonary hypertension in sepsis: measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors. Chest 73:583-591.
3. Vito, L., R. C. Dennis, R. D. Weisel, and H. B. Hechtman. 1974. Sepsis presenting as acute respiratory insufficiency. Surg. Gynecol. Obstet. 138:896-900.
4. Brigham, K. L., and B. Meyrick. 1986. Endotoxin and lung injury. Am. Rev. Respir. Dis. 133:913-927.
5. Esbenshade, A. M., J. H. Newman, P. M. Lams, H. Jolles, and K. L. Brigham. 1982. Respiratory failure after endotoxin infusion in sheep: lung mechanics and lung fluid balance. J. Appl. Physiol.: Respir. Environ. & Physiol. 53:967-976.
6. Ogletree, M. L., C. J. Begley, G. A. King, and K. L. Brigham. 1986. Influence of steroidal and nonsteroidal anti-inflammatory agents on the accumulation of arachidonic acid metabolites in plasma and lung lymph after endotoxemia in awake sheep: measurements of prostacyclin and thromboxane metabolites and 12-HETE. Am. Rev. Respir. Dis. 133: 55-61.
7. Ogletree, M. L., and K. L. Brigham. 1982. Effects of cyclooxygenase inhibitors on pulmonary vascular responses to endotoxin in unanesthetized sheep. Prostaglandins Leukot. Med. 8:489-502.
8. Snapper, J. R., A. A. Hutchinson, M. L. Ogletree, and K. L. Brigham. 1983. Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. J. Clin. Invest. 72:63-76.
9. Ball, H. A., J. R. Parratt, and I. J. Zeitlin. 1983. Effect of dazoxiben, a specific inhibitor of thromboxane synthetase, on acute pulmonary responses to E. coli endotoxin in anesthetized cats. Br. J. Clin. Pharmacol. 15(Suppl. 1):127S-131S.
10. Casey, L. C., J. R. Fletcher, M. I. Zmudka, and P. W. Ramwell. 1982. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581. J. Pharmacol. Exp. Ther. 222:441-446.
11. Kubo, K., and T. Kobayashi. 1985. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep. Am. Rev. Respir. Dis. 132:494-499.
12. Watkins, W. D., P. C. Huttemeier, D. Kong, and M. B. Peterson. 1982. Thromboxane and pulmonary hypertension following E. coli endotoxin infusion in sheep: effect of an imidazole derivative. Prostaglandins 23:273-285.
13. Winn, R., J. Harlan, B. Nadir, L. Harker, and J. Hildebrandt. 1983. Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin. J. Clin. Invest. 72:911-918.
14. Kuhl, P. G., J. M. Bolds, J. E. Loyd, J. R. Snapper, and G. A. FitzGerald. 1988. Thromboxane receptor-mediated bronchial and hemodynamic responses in ovine endotoxemia. Am. J. Physiol. 254:R310-R319.
15. Schumacher, W. A., H. D. Adams, and M. L. Ogletree. 1987. Effect of the thromboxane A2-receptor antagonists, SQ 29,548 and SQ 28,668, on the pulmonary hypertensive response to endotoxemia in swine. Pharmacology 34:301-308.
16. Morel, D. R., J. F. Pittet, K. Gunning, A. Hemsen, J. S. Lacroix, and J. M. Lundberg. 1991. Time course of plasma and pulmonary lymph endothelin-like immunoreactivity during sustained endotoxaemia in chronically instrumented sheep. Clin. Sci. 81:357-365.
17. Pernow, J., A. Hemsen, and J. M. Lundberg. 1989. Increased plasma levels of endothelin-like immunoreactivity during endotoxin administration in the pig. Acta Physiol. Scand. 137:317-318.
18. Rummel, T. E., R. E. Parker, J. T. Conary, and K. L. Brigham. 1992. Time course of endotoxin-induced lung endothelin-1 production in sheep (abstract). Am. Rev. Respir. Dis. 145:A850.
19. Sugiura, M., T. Inagami, and V. Kon. 1989. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun. 161:1220-1227.
20. Pittet, J. F., D. R. Morel, A. Hemsen, K. Gunning, J. S. Lacroix, P. M. Suter, and J. M. Lundberg. 1991. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann. Surg. 213:261-264.
21. Lippton, H. L., E. H. Ohlstein, W. R. Summer, and A. L. Hyman. 1991. Analysis of responses to endothelins in the rabbit pulmonary and systemic vascular beds. J. Appl. Physiol. 70:331-341.
22. Rodman, D. M., I. F. McMurtry, J. L. Peach, and R. F. O'Brien. 1989. Comparative pharmacology of rat and porcine endothelin in rat aorta and pulmonary artery. Eur. J. Pharmacol. 165:297-300.
23. Lippton, H. L., T. A. Hauth, W. R. Summer, and A. L. Hyman. 1989. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. J. Appl. Physiol. 66:1008-1012.
24. Mann, J., I. S. Farrukh, and J. R. Michael. 1991. Mechanisms by which endothelin 1 induces pulmonary vasoconstriction in the rabbit. J. Appl. Physiol. 71:410-416.
25. Pons, F., I. Loquet, C. Touvay, P. Roubert, P. E. Chabrier, J. M. Mencia-Huerta, and P. Braquet. 1991. Comparison of the bronchopulmonary and pressor activities of endothelin isoforms ET-1, ET-2, and ET-3 and characterization of their binding sites in guinea pig lung. Am. Rev. Respir. Dis. 143:294-300.
26. Hay, D. W., P. J. Henry, and R. G. Goldie. 1993. Endothelin and the respiratory system. Trends Pharmacol. Sci. 14:29-32.
27. Sokolovsky, M. 1992. Endothelins and sarafotoxins: physiological regulation, receptor subtypes and transmembrane signaling. Pharmacol. Ther. 54:129-149.
28. Nakamichi, K., M. Ihara, M. Kobayashi, T. Saeki, K. Ishikawa, and M. Yano. 1992. Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Ala1,3,11,15]ET-1. Biochem. Biophys. Res. Commun. 182:144-150.
29. Begley, C. J., M. L. Ogletree, B. O. Meyrick, and K. L. Brigham. 1984. Modification of pulmonary responses to endotoxemia in awake sheep by steroidal and nonsteroidal anti-inflammatory agents. Am. Rev. Respir. Dis. 130:1140-1146.
30. Staub, N. C., R. D. Bland, K. L. Brigham, R. Demling, A. J. Erdmann, and W. C. Woolverton. 1975. Preparation of chronic lung lymph fistulas in sheep. J. Surg. Res. 19:315-320.
31. von Neergaard, K., and K. Wirz. 1927. Über eine Methode zur Messung der Lungenelastizität am lebenden Menschen, inbesondere beim Emphysem. Z. Klin. Med. 105:35-50.
32. Coleman, R. A., P. P. Humphrey, I. Kennedy, G. P. Levy, and P. Lumley. 1981. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br. J. Pharmacol. 73:773-778.
33. Failing, J., M. Buckley, and D. Zak. 1960. Automatic determination of serum proteins. Am. J. Clin. Pathol. 33:83-88.
34. Anggard, E. E., R. M. Botting, and J. R. Vane. 1990. Endothelins. Blood Vessels 27:269-281.
35. Masaki, T., S. Kimura, M. Yanagisawa, and K. Goto. 1991. Molecular and cellular mechanism of endothelin regulation: implications for vascular function. Circulation 84:1457-1468.
36. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
37. Yanagisawa, M., and T. Masaki. 1989. Molecular biology and biochemistry of the endothelins. Trends Pharmacol. Sci. 10:374-378.
38. Snapper, J. R., J. M. Hinson, Jr., A. A. Hutchison, P. L. Lefferts, M. L. Ogletree, and K. L. Brigham. 1984. Effects of platelet depletion on the unanesthetized sheep's pulmonary response to endotoxemia. J. Clin. Invest. 74:1782-1791.
39. Abraham, W. M., A. Ahmed, A. Cortes, M. J. Spinella, A. B. Malik, and T. T. Andersen. 1993. A specific endothelin-1 antagonist blocks inhaled endothelin-1-induced bronchoconstriction in sheep. J. Appl. Physiol. 74:2537-2542.